Mediators of the benefit of sotagliflozin in patients with worsening heart failure in SOLOIST-WHF

被引：0
|
作者：
Szarek, M. [1 ]
Bhatt, D. [2 ]
Steg, P. G. [3 ]
Davies, M. J. [4 ]
Pitt, B. [5 ]
机构：
[1] Univ Colorado, Sch Med, Aurora, CO USA
[2] Mt Sinai Heart, New York, NY USA
[3] Univ Paris Diderot, Bichat Hosp, FACT French Alliance Cardiovasc T, INSERM,UMR1148, Paris, France
[4] Lexicon, Basking Ridge, NJ USA
[5] Univ Michigan, Ann Arbor, MI USA
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Sotagliflozin versus dapagliflozin to improve outcome of patients with diabetes and worsening heart failure: a cost per outcome analysis
    Zhang, Weichen
    Yu, Meichen
    Cheng, Guohua
    [J]. FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [22] The impact of worsening heart failure (WHF) status on subsequent outcomes among patients with HFrEF: History of WHF events is associated with worse subsequent outcomes regardless of extent of GDMT
    Coyle, C.
    Ru, B.
    Ambrosy, A. P.
    Mcmullen, C. J.
    Stevenson, A. S.
    Ai, L.
    Bash, L. D.
    Gaggin, H. K.
    [J]. EUROPEAN HEART JOURNAL, 2023, 44
  • [23] Sotagliflozin, A Dual SGLT1 And SGLT2 Inhibitor, Reduces First And Subsequent Heart Failure-related Events In Patients Admitted For Worsening Heart Failure
    Pitt, Bertram
    Szarek, Michael
    Banks, Phillip
    Sun, Franklin
    Davies, Michael
    Bhatt, Deepak
    [J]. JOURNAL OF CARDIAC FAILURE, 2023, 29 (04) : 683 - 684
  • [24] The value of sotagliflozin in patients with diabetes and heart failure detracted by an unexpected ending
    Volpe, Massimo
    Patrono, Carlo
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 (15) : 1458 - 1459
  • [25] QT dynamicity in patients with worsening heart failure
    Uchiyama, T
    Watanabe, E
    Arakawa, T
    Yasui, K
    Kodama, I
    Hishida, H
    [J]. JOURNAL OF CARDIAC FAILURE, 2004, 10 (05) : S165 - S165
  • [26] Efficacy and safety of the dual SGLT1 and 2 inhibitor sotagliflozin in combination with a mineralocorticoid receptor antagonist in patients hospitalized for worsening heart failure
    Pitt, B.
    Bhatt, D. L.
    Szarek, M.
    Davies, M.
    Banks, P.
    Steg, P. G.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 192 - 193
  • [27] Optimizing the management of patients with worsening heart failure: beyond heart failure hospitalization
    Fernandez, Alberto Esteban
    Mayoral, Alejandro Recio
    Franco, Alvaro Gonzalez
    Villota, Julio Nunez
    Mirabet, Sonia
    Gracia, Jorge Rubio
    Costello, Jose Gonzalez
    Palomas, Juan Luis Bonilla
    Cervantes, Carlos Escobar
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (06) : 705 - 713
  • [28] In-hospital worsening heart failure in patients admitted for acute heart failure
    Carubelli, Valentina
    Cotter, Gad
    Davison, Beth
    Gishe, Jemal
    Senger, Stefanie
    Bonadei, Ivano
    Gorga, Elio
    Lazzarini, Valentina
    Lombardi, Carlo
    Metra, Marco
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 225 : 353 - 361
  • [29] Role of betablockers in patients admitted for worsening heart failure
    Orso, F.
    Baldasseroni, S.
    Fabbri, G.
    Gonzini, L.
    Lucci, D.
    Randazzo, S.
    Lecchi, G.
    Maggioni, A. P.
    [J]. EUROPEAN HEART JOURNAL, 2007, 28 : 17 - 17
  • [30] Prognostic significance of worsening heart failure in patients hospitalized for acute decompensated heart failure
    Dabrowska, E.
    Okoye, S.
    Warmowska-Dawid, A.
    Gruchala, M.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 44 - 44
12345